trofosfamide has been researched along with Cancer of Prostate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Han, R; Hu, H; Tao, W; Wang, C; Wen, XY | 1 |
| Coras, B; Hafner, C; Landthaler, M; Reichle, A; Vogt, T | 1 |
| Brock, N | 1 |
1 review(s) available for trofosfamide and Cancer of Prostate
| Article | Year |
|---|---|
SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Case-Control Studies; Cyclophosphamide; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms | 2010 |
2 other study(ies) available for trofosfamide and Cancer of Prostate
| Article | Year |
|---|---|
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Capecitabine; Cyclophosphamide; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Paraneoplastic Syndromes; Pioglitazone; Prostatic Neoplasms; Thiazolidinediones | 2006 |
Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.
Topics: Alkylating Agents; Antineoplastic Agents; Biotransformation; Cyclophosphamide; Female; Humans; Ifosfamide; Inactivation, Metabolic; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms; Structure-Activity Relationship; Sulfhydryl Compounds | 1986 |